Sweet taste and nonnutritive suckling produce analgesia to transient noxious stimuli in infant rats and humans. The present study evaluated the pain-modulating effects of sucrose and suckling in a rat model of persistent pain and hyperalgesia that mimics the response to tissue injury in humans. Fore-and hindpaw withdrawal latencies from a 30؇ or 48؇C brass stylus were determined in 10-day-old rats following paw inf lammation induced by complete Freund's adjuvant (CFA; 1:1 injected s.c. in a 0.01 ml volume). CFA markedly decreased escape latencies to both 48؇ and 30؇C stimulation, thereby demonstrating thermal hyperalgesia and mechanical allodynia. The combination of nonnutritive suckling and sucrose (7.5%, 0.01-0.06 ml͞min) infusion markedly increased escape latencies to forepaw stimulation in both CFA-treated and control rats. In contrast, intraoral sucrose and suckling did not increase hindpaw withdrawal latencies in either control or CFA-inf lamed rats. The effect was specific to sweet taste because neither water nor isotonic saline infusion affected forepaw escape latencies. Parallel findings were obtained for CFA-induced Fos-like immunoreactivity (Fos-LI), a marker of neuronal activation. Fos-LI was selectively induced in cervical and lumbar regions ipsilateral to forepaw and hindpaw inf lammation, respectively. Suckling-sucrose treatment significantly reduced Fos-LI at the cervical but not at the lumbar regions. These findings demonstrate: (i) the development of persistent pain and hyperalgesia in 10-day-old rats that can be attenuated by endogenous pain-modulating systems activated by taste and nonnutritive suckling; (ii) the mediation of the sucrose-suckling analgesia and antihyperalgesia at the spinal level; and (iii) a differential rostrocaudal maturation of descending pain-modulating systems to the spinal cord of 10-day-old rats. These findings may provide new clinical approaches for engaging endogenous analgesic mechanisms in infants following tissue injury and inf lammation.Pain is a serious clinical problem in premature, newborn, and young infants that arises from medical or surgical intervention or traumatic injury. Although the commonly held view that infants do not perceive pain has been refuted (1), the fear that anesthetic agents produce respiratory depression, apnea, and hypotension in this population persists, and insufficient pain control remains an important clinical problem following common medical or surgical procedures (2). Recent behavioral studies demonstrating orogustatory and orotactile-induced analgesia hold considerable potential for the future management of pain in newborns through noninvasive means that engage endogenous analgesic systems (3, 4). In particular, calming, analgesia, and (in humans) bradycardia can be induced via sweet (sucrose, fructose, or glucose) or milk stimulation, but not lactose in both rat (5-8) and human infants (9-14).The calming and analgesic effects of orogustatory stimulation appear to be opioid-mediated. Sucrose-and milk-induced calming and a...